BTG2 and ovarian carcinoma: We found that the proliferation of ovarian cancer cells was inhibited by BTG2 and confirmed the effects and mechanisms of BTG2-sensitized ovarian cancer by establishing nude mouse xenograft models using the BTG2 shRNA- and NC-transfected A2780 cells.